479 related articles for article (PubMed ID: 25631522)
1. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N
Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522
[TBL] [Abstract][Full Text] [Related]
2. Editorial Comment to Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
Zhang Z; Zhou F
Int J Urol; 2015 May; 22(5):467-8. PubMed ID: 25808233
[No Abstract] [Full Text] [Related]
3. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
Kuroda K; Asakuma J; Asano T; Horiguchi A; Isono M; Tsujita Y; Sato A; Seguchi K; Ito K; Asano T
Jpn J Clin Oncol; 2015 Jan; 45(1):103-10. PubMed ID: 25324479
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of Preoperative Anemia on Urothelial and Extraurothelial Recurrence in Patients With Upper Tract Urothelial Carcinoma.
Milojevic B; Dzamic Z; Kajmakovic B; Durutovic O; Bumbasirevic U; Sipetic Grujicic S
Clin Genitourin Cancer; 2015 Oct; 13(5):485-91. PubMed ID: 25920995
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma.
Munari E; Fujita K; Faraj S; Chaux A; Gonzalez-Roibon N; Hicks J; Meeker A; Nonomura N; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2668-76. PubMed ID: 24074531
[TBL] [Abstract][Full Text] [Related]
6. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of preoperative plasma fibrinogen level in patients with upper urinary tract urothelial carcinoma: A retrospective tumor marker prognostic study.
Liu R; Zhou X; Zou L; Chen Q; Hu Y; Hu J; Wu X; Jiang H
Int J Surg; 2019 May; 65():88-93. PubMed ID: 30951871
[TBL] [Abstract][Full Text] [Related]
11. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
12. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy.
Kusuda Y; Miyake H; Terakawa T; Kondo Y; Miura T; Fujisawa M
Urol Oncol; 2013 Aug; 31(6):899-903. PubMed ID: 21824792
[TBL] [Abstract][Full Text] [Related]
13. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
[TBL] [Abstract][Full Text] [Related]
14. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Fan B; Hu B; Yuan Q; Wen S; Liu T; Bai S; Qi X; Wang X; Yang D; Sun X; Song X
Tumour Biol; 2017 Jul; 39(7):1010428317710822. PubMed ID: 28714362
[TBL] [Abstract][Full Text] [Related]
16. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association.
Hara T; Fujimoto H; Sakura M; Inokuchi J; Nishiyama H; Miyazaki J; Ohyama C; Koie T; Kikuchi E; Hinotsu S;
Int J Urol; 2015 Nov; 22(11):1013-20. PubMed ID: 26242807
[TBL] [Abstract][Full Text] [Related]
18. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
[TBL] [Abstract][Full Text] [Related]
19. Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
Narukawa T; Hara T; Arai E; Komiyama M; Kawahara T; Kanai Y; Fujimoto H
Jpn J Clin Oncol; 2015 May; 45(5):488-93. PubMed ID: 25681388
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.
Fradet V; Mauermann J; Kassouf W; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Tanguay S; Chin J; So A; Lattouf JB; Bell D; Saad F; Sheyegan B; Drachenberg D; Cagiannos I; Lacombe L
Urol Oncol; 2014 Aug; 32(6):839-45. PubMed ID: 24856978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
